Supreme Court Seems Sympathetic To Insurers In Obamacare Case
Justices from the right and left ask whether Congress needs to keep its promises.
The independent source for health policy research, polling, and news.
501 - 520 of 985 Results
Justices from the right and left ask whether Congress needs to keep its promises.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you dont have to.
The annual accounting of national health spending is out. And the 2018 health bill for the U.S. was $3.6 trillion, consuming nearly a fifth of the nations economy. Meanwhile, Congress is nearing the end of the year without having finished either its annual spending bills or several other high-priority health items. Kimberly Leonard of the Washington Examiner, Joanne Kenen of Politico and Mary Agnes Carey of Kaiser Health News join KHNs Julie Rovner to discuss this and more. Also, Rovner interviews KHNs Markian Hawryluk about the latest KHN-NPR Bill of the Month.
The pharmaceutical industrys argument that capping drug prices would compromise drug innovation stands on very shaky ground.
Open enrollment for the Affordable Care Acts marketplace plans is halfway over and, so far, the number of people signing up is down, but not dramatically. Meanwhile, Congress and President Donald Trump cant seem to agree on what to do about teen vaping, drug prices or surprise medical bills. And Democrats lurch to the left on abortion. Paige Winfield Cunningham of The Washington Post, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHNs Julie Rovner to discuss this and more health news.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Special interests and congressional inaction blocked efforts to track the safety of electronic medical records, leaving patients at risk.
When passing the Affordable Care Act, Democrats touted the fact that they had included many measures to pay for the bills expanded coverage. But nearly 10 years later, many of the pay-fors have been eliminated.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you dont have to.
Its November, do you know where your HHS spending bill is? Still stuck in Congress. Meanwhile, lawmakers move ahead on restricting tobacco products for youth while the administrations proposal is MIA. Rebecca Adams of CQ Roll Call and Alice Miranda Ollstein of Politico join KHNs Julie Rovner to discuss this and more health news from the week. Also, Rovner interviews Dan Weissmann, host of the podcast An Arm and a Leg.
Nearly 8 in 10 Americans say the cost of prescription drugs is unreasonable, but the odds look grim for Congress to pass significant pricing legislation this year.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you dont have to.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you dont have to.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you dont have to.
A letter from the Senate Finance Committee chairman questions the University of Virginia Health System about its financial assistance policies, billing practices and prices.
House Democrats start legislative work on House Speaker Nancy Pelosis prescription drug pricing bill; health is again a featured player in the Democratic presidential candidate debate; and courts around the country hold up President Donald Trumps health agenda. This week, Margot Sanger-Katz of The New York Times, Tami Luhby of CNN, and Joanne Kenen of Politico join KHNs Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health stories of the week.
Washington is abuzz with impeachment talk, but what impact would such a move have on congressional action on prescription drug prices and surprise bills? Also, a study out this week shows that health insurance costs for both employers and workers continue to rise. This week, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHNs Julie Rovner to discuss these issues and more.
A hearing before a House Oversight and Reform Committee panel on how to address the crisis of respiratory injuries related to vaping turned surprisingly partisan.
The House speaker announced her plan for lowering drug prices, which includes negotiations between drugmakers and federal health officials.
Tennessee wants to convert its Medicaid program to a block grant. But is its plan legal? Meanwhile, Congress continues to struggle with legislation to rein in prescription drug prices and surprise medical bills. This week, Anna Edney of Bloomberg News, Jennifer Haberkorn of the Los Angeles Times and Kimberly Leonard of the Washington Examiner join KHNs Julie Rovner to discuss these issues and more. Rovner also interviews Dr. Marty Makary, author of the new book The Price We Pay about why health care costs so much.
穢 2026 KFF